Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avita Medical (RCEL)
NASDAQ:RCEL
Holding RCEL?
Track your performance easily
RCEL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.51 - $18.93
Previous CloseN/A
Volume824.49K
Average Volume (3M)199.51K
Market Cap
$223.90M
Enterprise Value$279.77M
Total Cash (Recent Filing)$4.67K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.35
Next Earnings
Feb 13, 2025EPS Estimate
-0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.23
Shares Outstanding26,217,628
10 Day Avg. Volume356,549
30 Day Avg. Volume199,511
Standard Deviation0.20
R-Squared0.17
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.73
Price to Cash Flow (P/CF)-7.80
P/FCF Ratio0.00
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue4.66
Enterprise Value/Gross Profit6.60
Enterprise Value/Ebitda-5.47
Forecast
1Y Price Target
$17.40Price Target Upside101.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Avita Medical News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company's flagship RECELL platform is generating nice traction, as evidenced by the 29% revenue growth performance.
Market ExpansionThe FDA's approval of RECELL for broader applications expanded the Company's market reach, underscoring the product's versatility and efficacy.
Product DevelopmentFDA has granted 510(k) clearance for Cohealyx, a new collagen-based dermal matrix branded by AVITA Medical, which enhances AVITA’s comprehensive portfolio for addressing full-thickness wound care.
Bears Say
Guidance ExpectationsThe company has lowered its guidance expectations for the fourth time in the past five quarters.
Product LaunchRCEL's launch of RECELL GO into full-thickness skin defects has progressed slower than expected.
Valuation ConcernsThe company's valuation suggests that its multiples may compress or stagnate until there is improved confidence in its growth ramp.
---
Ownership Overview
1.15% Insiders
8.49% Mutual Funds
0.30% Other Institutional Investors
80.60% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RCEL FAQ
What was Avita Medical’s price range in the past 12 months?
Avita Medical lowest stock price was $7.51 and its highest was $18.93 in the past 12 months.
What is Avita Medical’s market cap?
Avita Medical’s market cap is $223.90M.
When is Avita Medical’s upcoming earnings report date?
Avita Medical’s upcoming earnings report date is Feb 13, 2025 which is in 23 days.
How were Avita Medical’s earnings last quarter?
Avita Medical released its earnings results on Nov 07, 2024. The company reported -$0.62 earnings per share for the quarter, missing the consensus estimate of -$0.434 by -$0.186.
Is Avita Medical overvalued?
According to Wall Street analysts Avita Medical’s price is currently Undervalued.
Does Avita Medical pay dividends?
Avita Medical does not currently pay dividends.
What is Avita Medical’s EPS estimate?
Avita Medical’s EPS estimate is -0.39.
How many shares outstanding does Avita Medical have?
Avita Medical has 26,217,628 shares outstanding.
What happened to Avita Medical’s price movement after its last earnings report?
Avita Medical reported an EPS of -$0.62 in its last earnings report, missing expectations of -$0.434. Following the earnings report the stock price went down -3.629%.
Which hedge fund is a major shareholder of Avita Medical?
Among the largest hedge funds holding Avita Medical’s share is Hussman Strategic Advisors Inc. It holds Avita Medical’s shares valued at 0.
---
Avita Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.40 (101.16% Upside)
$17.40 (101.16% Upside)
Blogger Sentiment
Bullish
RCEL Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 42.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $12.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 11.9%
Last 30 Days ▲ 11.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-37.76%
12-Months-Change
Fundamentals
Return on Equity
-152.44%
Trailing 12-Months
Asset Growth
0.05%
Trailing 12-Months
Company Description
Avita Medical
Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company was founded on December 21, 1992 and is headquartered in Royston, the United Kingdom.
---
RCEL Company Deck
---
RCEL Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong commercial revenue growth, successful product transitions, and a positive outlook with new product launches and international expansion plans. However, it also noted increased operating expenses, a significant net loss, and delays in international approvals. Despite these challenges, the company maintains a positive growth trajectory.Read More>---
RCEL Revenue Breakdown
99.27% Commercial sales
0.67% Services for emergency preparedness
0.07% Deferred commercial revenue
---
RCEL Stock 12 Month Forecast
Average Price Target
$17.40
▲(101.16% Upside)
Technical Analysis
MiMedx Group
―
Krystal Biotech
―
Conmed
―
Vericel
―
Karyopharm Therapeutics
―
TransMedics Group
―
Best Analysts Covering RCEL
1 Year
1 Year Success Rate
5/13 ratings generated profit
1 Year Average Return
-15.05%
reiterated a buy rating 15 days ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 38.46% of your transactions generating a profit, with an average return of -15.05% per trade.
---